Vanta Bioscience Limited (VANTABIO.BO)

INR 42.57

(0.0%)

Operating Expenses Summary of Vanta Bioscience Limited

  • Vanta Bioscience Limited's latest annual operating expenses in 2023 was 38.95 Million INR , up 4.42% from previous year.
  • Vanta Bioscience Limited's latest quarterly operating expenses in 2023 FY was 38.95 Million INR , up 4.42% from previous quarter.
  • Vanta Bioscience Limited reported a annual operating expenses of 37.3 Million INR in annual operating expenses 2022, up 52.66% from previous year.
  • Vanta Bioscience Limited reported a annual operating expenses of 24.43 Million INR in annual operating expenses 2021, up 1.56% from previous year.
  • Vanta Bioscience Limited reported a quarterly operating expenses of 16.35 Million INR for 2023 Q2, down -16.19% from previous quarter.
  • Vanta Bioscience Limited reported a quarterly operating expenses of 22.6 Million INR for 2023 Q4, up 38.17% from previous quarter.

Annual Operating Expenses Chart of Vanta Bioscience Limited (2023 - 2017)

Historical Annual Operating Expenses of Vanta Bioscience Limited (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 38.95 Million INR 4.42%
2022 37.3 Million INR 52.66%
2021 24.43 Million INR 1.56%
2020 24.06 Million INR -20.8%
2019 30.38 Million INR -18.35%
2018 37.21 Million INR 475.5%
2017 6.46 Million INR 0.0%

Peer Operating Expenses Comparison of Vanta Bioscience Limited

Name Operating Expenses Operating Expenses Difference
Alfavision Overseas (India) Limited 1.24 Million INR -3041.774%
Biocon Limited 40.9 Billion INR 99.905%
Blue Jet Healthcare Limited 531.85 Million INR 92.675%
Concord Biotech Limited 1.45 Billion INR 97.331%
Dishman Carbogen Amcis Limited 5.14 Billion INR 99.243%
FERMENTA BIOTECH LIMITED 754.2 Million INR 94.835%
GENOMIC VALLEY BIOTECH LIMITED 375 Thousand INR -10288.8%
Lyka Labs Limited 599.4 Million INR 93.501%
Panacea Biotec Limited 1.99 Billion INR 98.048%
SAMSRITA LABS LIMITED 1.49 Million INR -2501.744%
Servoteach Industries Limited 785.00 INR -4962702.548%
SMS Lifesciences India Limited 602.96 Million INR 93.539%
Supriya Lifescience Limited 1.08 Billion INR 96.393%
Syngene International Limited 5.99 Billion INR 99.35%
TAKE Solutions Limited 396.91 Million INR 90.185%
Titan Biotech Limited 117.05 Million INR 66.719%
Transgene Biotek Limited 5.39 Million INR -621.845%